These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8601932)

  • 1. End-stage renal disease therapy: an American success story.
    Friedman EA
    JAMA; 1996 Apr; 275(14):1118-22. PubMed ID: 8601932
    [No Abstract]   [Full Text] [Related]  

  • 2. The social contract and the treatment of permanent kidney failure.
    Rettig RA
    JAMA; 1996 Apr; 275(14):1123-6. PubMed ID: 8601933
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical issues in geriatric nephrology: overview.
    Cummings NB
    Am J Kidney Dis; 1990 Oct; 16(4):367-71. PubMed ID: 2220788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of services in managed care: guidelines for use of renal dialysis.
    Paris JJ; Moss AH
    Trends Health Care Law Ethics; 1995; 10(1-2):101-4. PubMed ID: 7655217
    [No Abstract]   [Full Text] [Related]  

  • 5. Limited resources and the treatment of end-stage renal failure in Britain and the United States.
    Rennie D; Rettig RA; Wing AJ
    Q J Med; 1985 Jul; 56(219):321-36. PubMed ID: 3912791
    [No Abstract]   [Full Text] [Related]  

  • 6. The graying of dialysis in America.
    Jones FS
    N C Med J; 1996; 57(6):359-62. PubMed ID: 8937160
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationing of health care and the end-stage renal disease program.
    Klahr S
    Am J Kidney Dis; 1990 Oct; 16(4):392-5. PubMed ID: 2220792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of renal replacement therapy in Austria.
    Haller M; Gutjahr G; Kramar R; Harnoncourt F; Oberbauer R
    Nephrol Dial Transplant; 2011 Sep; 26(9):2988-95. PubMed ID: 21310740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truth lies somewhere, if we knew but where.
    Nicholson RH
    Hastings Cent Rep; 1993; 23(5):5. PubMed ID: 8262771
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrology and the rationing of health care.
    Friedman EA
    Contrib Nephrol; 1993; 102():220-36. PubMed ID: 8416184
    [No Abstract]   [Full Text] [Related]  

  • 11. Justice and cost-containment in end-stage renal disease.
    Johnstone BV
    J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
    [No Abstract]   [Full Text] [Related]  

  • 12. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 13. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 14. X. The economic cost of ESRD and Medicare spending for alternative modalities of treatment.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S124-39. PubMed ID: 10431009
    [No Abstract]   [Full Text] [Related]  

  • 15. Kidneys, ethics, and politics: policy lessons of the ESRD experience.
    Caplan AL
    J Health Polit Policy Law; 1981; 6(3):488-503. PubMed ID: 7033349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of renal replacement therapies: how should we design research on these interventions in Brazil?].
    Sancho LG; Dain S
    Cad Saude Publica; 2008 Jun; 24(6):1279-90. PubMed ID: 18545754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
    Arrieta J; Rodríguez-Carmona A; Remón C; Pérez-Fontán M; Ortega F; Sánchez Tomero JA; Selgas R
    Nefrologia; 2011; 31(5):505-13. PubMed ID: 21959716
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost consideration in renal replacement therapy in Kenya.
    Were AJ; McLigeyo SO
    East Afr Med J; 1995 Jan; 72(1):69-71. PubMed ID: 7781562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
    Gutman RA
    Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.